ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
95 hedge funds and large institutions have $391M invested in Adamas Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 30 increasing their positions, 27 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
11% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 27
4% less call options, than puts
Call options by funds: $8.72M | Put options by funds: $9.07M
Holders
95
Holding in Top 10
4
Calls
$8.72M
Puts
$9.07M
Top Buyers
| 1 | +$19.5M | |
| 2 | +$16.2M | |
| 3 | +$15.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$15.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$15.6M |
Top Sellers
| 1 | -$41.5M | |
| 2 | -$8.64M | |
| 3 | -$5.77M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$5.07M |
| 5 |
OTPPB
Ontario Teachers' Pension Plan Board
Toronto,
Ontario, Canada
|
-$4.33M |